In short. Glabellar lines are the vertical frown lines between the eyebrows, formed where the corrugator and procerus muscles crease the skin. Botulinum toxin reduces that muscle pull and treats the area more predictably than almost any other, but established static creases may need more than relaxation.
Key points
- Three small muscles drive the frown: the corrugator pair and the procerus.
- Frown patterns differ between people, so assessment maps the pattern rather than a template.
- Lines that appear only on frowning usually smooth with muscle relaxation alone.
- A crease visible at rest may also need filler or resurfacing in combination.
- The main risk is temporary eyelid droop from product tracking, uncommon with careful placement.
What causes glabellar lines?
The vertical lines between the eyebrows, often called frown lines or glabellar lines, form where the muscles that draw the brows together and down crease the skin with every squint, frown or moment of concentration. They can give an unintended look of anger or worry. Three small muscles drive the frown: the corrugator pair that pull the brows inward, and the procerus that pulls the skin down between them.
Their strength and arrangement vary between people, which is why some frown patterns produce one central line, others two parallel lines, and others a more diagonal crease. Assessment maps the individual pattern rather than injecting a standard template.
How botulinum toxin works here
As elsewhere, botulinum toxin temporarily reduces the signal telling these muscles to contract, so the skin between the brows is folded less. Because the glabellar muscles are small, well-defined, and lie away from the muscles that open the eye, treatment here is reliable and forgiving. Results typically last three to six months.
Dynamic lines and static lines
When lines appear only with frowning, muscle relaxation alone usually smooths them. When a deep crease remains visible at rest, years of folding have etched the skin itself; toxin prevents further deepening and lets the crease soften over repeated cycles, but established static lines sometimes benefit from careful filler placement or skin resurfacing in combination. Honest planning means saying which category a given line falls into.
Who is a candidate?
Most adults bothered by frown lines are reasonable candidates. Treatment should be deferred during pregnancy and breastfeeding and avoided with certain neuromuscular conditions. People whose main concern is brow position or eyelid heaviness rather than the lines themselves need a broader upper-face assessment first. A qualified medical consultation precedes any treatment decision.
How is treatment planned?
Assessment identifies which muscles dominate the individual frown pattern and how strongly they act. Treatment places conservative doses at several mapped points, usually coordinated with forehead planning so brow position stays balanced. A review at two to three weeks checks symmetry and residual movement; small refinement, not escalation, is the rule. Later sessions are adjusted to the response already observed.
| Line or pattern | What produces it | How it is assessed | What treatment aims at |
|---|---|---|---|
| One central line | The procerus pulling the skin down between the brows | Which muscle dominates the pattern | Reducing the pull of the procerus |
| Two parallel lines | The corrugator pair pulling the brows inward | The strength and arrangement of the pair | Reducing the pull of the corrugator pair |
| A diagonal crease | Individual muscle strength and arrangement | The individual pattern rather than a template | Mapping the pattern before dosing |
| A line only on frowning | Muscle contraction | The dynamic category | Smoothing by muscle relaxation alone |
| A line visible at rest | Years of folding have etched the skin | The static category | Preventing further deepening, with filler or resurfacing in combination |
What is recovery like?
The procedure takes minutes with no downtime beyond avoiding rubbing and strenuous exercise for the day. Softening develops over three to seven days and matures by two weeks. Repeated treatments over years often allow slightly longer intervals as the frown habit weakens and the skin recovers.
The risk that matters here
Bruising and brief tenderness are the common, temporary effects. The risk that matters here is product tracking toward the muscle that lifts the eyelid, causing temporary droop, which is uncommon with careful placement and conservative dosing and usually resolves over weeks. Headache in the first day or two occurs in a minority and settles on its own.
When should a problem be reviewed?
An eyelid that droops, or a change in vision after treatment, is temporary but deserves prompt review and management. A deep crease between the brows that has changed shape rapidly, or skin within it that breaks down, deserves assessment, because etched lines change slowly. Pregnancy, breastfeeding or a neuromuscular condition means treatment should be deferred or avoided.
Sources
Internal links
Frequently asked questions
Why does the frown area respond so well to botulinum toxin?
The glabellar muscles are small, well defined, and lie away from the muscles that open the eye. That makes treatment here reliable and forgiving, with results typically lasting three to six months and high satisfaction.
Will toxin alone smooth a deep crease between my brows?
If the line appears only when you frown, muscle relaxation usually smooths it. A deep crease still visible at rest has been etched into the skin itself; toxin stops it deepening and lets it soften over repeated cycles, but careful filler placement or resurfacing may be needed too.
What is the main risk of treating the glabella?
Product tracking toward the muscle that lifts the eyelid, causing a temporary droop. It is uncommon with careful placement and conservative dosing, and usually resolves over weeks. Bruising, tenderness and a brief headache are the more common, temporary effects.
Risks & Limitations
- Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
- Nodules, lumps or granuloma formation, which may need treatment or dissolution.
- Infection at the injection site.
- Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
- Migration of filler away from the intended area.
- Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
- Bruising and swelling. All injectable results are temporary and maintenance is required.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
- A hard, painful lump that is growing.
- Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable safety information
- American Society of Plastic Surgeons (ASPS) — injectable guidance
- U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
- National Medical Products Administration (NMPA, China) — approved product status
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.